OncoSec Medical Incorporated

ONCS NASDAQ

LadyAmalthea12

$ONCS Target 7.20 for 25% Or next add level is at 4.32 — On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average. I start every position with 1% of my account and build from there as needed and as possible. I am not your financial advisor. Watch my setups first before you...

LadyAmalthea12

$ONCS Target 7.56 for 23.53% Or next add level is at 4.68 — On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average. I start every position with 1% of my account and build from there as needed and as possible. I am not your financial advisor. Watch my setups first before...

LadyAmalthea12

$ONCS Target 7.89 for 21.01% Or next add level is at 5.19 I am not your financial advisor. Watch my setups first before you jump in… My trade set ups work very well and they are for my personal reference and if you decide to trade them you do so at your own risk. I will gladly answer questions to the best of my knowledge but ultimately the risk is on you. I...

Weedkiller420

I like the MACD crossing and the break of the descending trendline. I want to see the price break $5.75 with some volume to enter for a swing trade. $6.54 target

KozakHlib

Contextual immersion trading strategy idea. OncoSec Medical Incorporated, a biotechnology company, focuses on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in...

altinAdam

Pls see chart. Good luck. Notes: 130 mln market cap 27mln shares outstanding OncoSec Medical, Inc. is a biotechnology company focused on designing, developing and commercializing therapies and proprietary medical approaches to stimulate and to guide an anti-tumor immune response for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an...

altinAdam

Pls see chart. Trade safe.

AlenCiken

OncoSec's Novel COVID-19 Vaccine Candidate Featured in 'Straight Talk' Program by NBC TV in Portland, Oregon OncoSec and researchers at Providence Cancer Institute previously announced a collaboration to conduct a first-in-human trial of OncoSec's CORVax12 vaccine candidate. Providence has filed an Investigator-Initiated Investigational New Drug (IND)...

19:58

Gann-Mode

A quick video on Multi time-frame analysis and of how it help give us more confidence in the lower time-frames, where we will make our entries and exits. Happy trading guys! 👍

kidusburr

earnings tonight, no pos.

mauretto432

ONCS = RICAPITALIZATION = CINA TURNAMNET TAVO = MONSTER ALLERT TOO = PAY ATTENTION THE TIME ON MONSTER TURNOVER IS NEAR ....

miqueldelrio91

Simply testing.

PennyStock101

*******POSSIBLE BREAKOUT IN BIO STOCK WITH NICE PRICE ACTION, INCREASED INTEREST AMONG TRADERS AS RUMORS AND SPECULATION FOLLOW THIS STOCK, KEEP ON WATCHLIST FOR A RAPID MOVE*************** AVERAGE ANALYSTS PRICE TARGET $9 AVERAGE ANALYSTS RECOMMENDATION BUY COMPANY PROFILE OncoSec Medical, Inc. is a biotechnology company, which engages in...

mauretto432

When, I say that passion goes beyond the imagination, I am led back to this title, believe me, in many years of studies and research in the field of biotechnology, there have been many satisfactions compared to dispaires. Well if I told you that ONCS, in the second half of 2019 and in the first three months of 2020, will officially present TAVO to the world as a...

whitejade

We got a double bottom here with an up gap in play. Waiting for volume to confirm. Purchasing at $.80 w/ a target of $1.20.

Will_Wong

Spring play.

mauretto432

13 MARCH 2019 OncoSec to Present at the 31st Annual ROTH Conference ONCS ..pay attention here from 0.50 tp 1 1.4 $

trademics

ONCE LOOKING GOOD ON THE PULLBACK LIKE LONG ON STRENGTH